Novartis Confident About Further Growth For 'Big Two'

New Indications On Track For Cosentyx And Entresto

 
• By Kevin Grogan
  
Vas Narasimhan
Vas Narasimhan says Cosenty and Entresto will hit 2025 sales targets • Source: Novartis
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D